2022 annual financial data
Artiva Biotherapeutics 2022 Net income growth
Direct answer
Net income growth was 18.71%.
Operating income was -59,829,000 USD and net income was -58,388,000 USD.
Operating cash flow was -50,829,000 USD.
Get free Artiva Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,931,000 USD
- Operating income
- -59,829,000 USD
- Net income
- -58,388,000 USD
- Operating cash flow
- -50,829,000 USD